Your browser doesn't support javascript.
loading
Chemoresistance is mediated by ovarian cancer leader cells in vitro.
Karimnia, Nazanin; Wilson, Amy L; Green, Emma; Matthews, Amelia; Jobling, Thomas W; Plebanski, Magdalena; Bilandzic, Maree; Stephens, Andrew N.
Afiliação
  • Karimnia N; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.
  • Wilson AL; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.
  • Green E; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.
  • Matthews A; Department of Molecular and Translational Sciences, Monash University, Clayton, Australia.
  • Jobling TW; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.
  • Plebanski M; Department of Molecular and Translational Sciences, Monash University, Clayton, Australia.
  • Bilandzic M; Monash Medical Centre, Department of Gynaecology Oncology, Monash Health, Moorabbin, Australia.
  • Stephens AN; School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia.
J Exp Clin Cancer Res ; 40(1): 276, 2021 Sep 01.
Article em En | MEDLINE | ID: mdl-34470672

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Resistencia a Medicamentos Antineoplásicos / Queratina-14 / Antineoplásicos Limite: Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Resistencia a Medicamentos Antineoplásicos / Queratina-14 / Antineoplásicos Limite: Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália